Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sectional Time-series Analysis, Multi-country Study.

NCT07154238 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT07154238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07154238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sectional Time-series Analysis, Multi-country Study.
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 26, 2025
Completion date
September 30, 2026
Enrollment
2,546 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity